Verified stock metrics
C4 Therapeutics, Inc. - Common Stock Key Stock Metrics
C4 Therapeutics, Inc. - Common Stock (CCCC) market cap, valuation, profitabilit…
Direct answer
C4 Therapeutics, Inc. - Common Stock has 8 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked August 5, 2026.
Verified data
- Market capitalization
- $399.15M
- Price-to-book ratio
- 1.6x
- Dividend yield
- 0%
- 52-week price range
- $1.69 to $5.17
- Return on equity
- -48.35%
- Revenue growth
- -15%
- Profit margin
- -297.76%
- Debt-to-equity ratio
- 24.95%
Explore related company data
View C4 Therapeutics, Inc. - Common Stock's market capitalizationView C4 Therapeutics, Inc. - Common Stock's price-to-book ratioView C4 Therapeutics, Inc. - Common Stock's dividend yieldView C4 Therapeutics, Inc. - Common Stock's 52-week price rangeView C4 Therapeutics, Inc. - Common Stock's return on equityView C4 Therapeutics, Inc. - Common Stock's revenue growthView C4 Therapeutics, Inc. - Common Stock's profit marginView C4 Therapeutics, Inc. - Common Stock's debt-to-equity ratioReturn to C4 Therapeutics, Inc. - Common Stock profile